Physician profile
Hannah Winget
NPI 1881221794
$1,504.05
in general payments reported to CMS, 2019-2025
18 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $115 · 2024: $1,204 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $334.27 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $254.78 | 2023-2025 | Farxiga, Breztri, Flumist Quadrivalent |
| Abbott Laboratories | $163.91 | 2024 | Freestyle Libre 3 |
| Abbvie INC. | $116.38 | 2023-2025 | Vraylar |
| Alkermes, INC. | $103.60 | 2024 | Vivitrol |
| Pfizer INC. | $86.98 | 2024 | |
| Merck Sharp & Dohme LLC | $77.72 | 2023-2025 | Gardasil 9, Vaxneuvance, Proquad |
| Glaxosmithkline, LLC. | $47.45 | 2024 | Trelegy Ellipta |
| Astellas Pharma US INC | $43.00 | 2024-2025 | Veozah |
| Lilly USA, LLC | $39.62 | 2024 | Zepbound, Jardiance, Mounjaro |
| Inspire Medical Systems, INC. | $38.95 | 2024 | Inspire |
| Amgen INC. | $37.52 | 2024 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.39 | 2024 | Ofev, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $35.59 | 2024 | |
| Lundbeck LLC | $32.84 | 2025 | Vyepti |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21.10 | 2023 | Spravato |
| Sumitomo Pharma America, INC. | $17.29 | 2024 | Gemtesa |
| Hologic Sales and Service, LLC | $15.66 | 2024 | Aptima, Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Winget listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.